Combined Beneficial Effect of Genistein and Atorvastatin on Adipogenesis in 3T3-L1 Adipocytes

Genistein (4,5,7-trihydroxyisoflavone) is abundant in various dietary vegetables, especially soybeans, and is known to have not only an estrogenic effect but also an antiadipogenic effect. Atorvastatin (dihydroxy monocarboxylic acid) is a statin used to prevent heart disease. Although genistein and...

Full description

Bibliographic Details
Main Authors: Dahae Lee, Ji-Youn Kim, Hae-Won Kim, Jeong-Eun Yoo, Ki Sung Kang
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/11/7/1052
_version_ 1797527526858293248
author Dahae Lee
Ji-Youn Kim
Hae-Won Kim
Jeong-Eun Yoo
Ki Sung Kang
author_facet Dahae Lee
Ji-Youn Kim
Hae-Won Kim
Jeong-Eun Yoo
Ki Sung Kang
author_sort Dahae Lee
collection DOAJ
description Genistein (4,5,7-trihydroxyisoflavone) is abundant in various dietary vegetables, especially soybeans, and is known to have not only an estrogenic effect but also an antiadipogenic effect. Atorvastatin (dihydroxy monocarboxylic acid) is a statin used to prevent heart disease. Although genistein and atorvastatin have been reported to possess antiadipogenic effects, their combined effects are still unclear. The aim of the current study was to explore whether the combination of genistein and atorvastatin at low concentrations significantly suppresses adipogenesis in a murine preadipocyte cell line (3T3-L1) compared to treatment with genistein or atorvastatin alone. Our results showed that cotreatment with 50 µM genistein and 50 nM atorvastatin significantly suppressed preadipocyte differentiation, whereas when each compound was used alone, there was no inhibitory effect. Additionally, cotreatment with genistein and atorvastatin significantly downregulated adipogenic marker proteins, including mitogen-activated protein kinases (MAPKs), peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer-binding protein alpha (C/EBPα), glucocorticoid receptor (GR), and CCAAT/enhancer-binding protein β (C/EBPβ). This is the first evidence of the combined antiadipogenic effects of genistein and atorvastatin. Although additional experiments are required, combinational treatment with genistein and atorvastatin may be an alternative treatment for menopause-associated lipid metabolic disorders and obesity.
first_indexed 2024-03-10T09:44:58Z
format Article
id doaj.art-5c12e366e0aa4a3d9e95c64793f35a1a
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T09:44:58Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-5c12e366e0aa4a3d9e95c64793f35a1a2023-11-22T03:19:29ZengMDPI AGBiomolecules2218-273X2021-07-01117105210.3390/biom11071052Combined Beneficial Effect of Genistein and Atorvastatin on Adipogenesis in 3T3-L1 AdipocytesDahae Lee0Ji-Youn Kim1Hae-Won Kim2Jeong-Eun Yoo3Ki Sung Kang4College of Korean Medicine, Gachon University, Seongnam 13120, KoreaDepartment of Obstetrics and Gynecology, College of Korean Medicine, Daejeon University, Daejeon 35235, KoreaDepartment of Obstetrics and Gynecology, College of Korean Medicine, Daejeon University, Daejeon 35235, KoreaDepartment of Obstetrics and Gynecology, College of Korean Medicine, Daejeon University, Daejeon 35235, KoreaCollege of Korean Medicine, Gachon University, Seongnam 13120, KoreaGenistein (4,5,7-trihydroxyisoflavone) is abundant in various dietary vegetables, especially soybeans, and is known to have not only an estrogenic effect but also an antiadipogenic effect. Atorvastatin (dihydroxy monocarboxylic acid) is a statin used to prevent heart disease. Although genistein and atorvastatin have been reported to possess antiadipogenic effects, their combined effects are still unclear. The aim of the current study was to explore whether the combination of genistein and atorvastatin at low concentrations significantly suppresses adipogenesis in a murine preadipocyte cell line (3T3-L1) compared to treatment with genistein or atorvastatin alone. Our results showed that cotreatment with 50 µM genistein and 50 nM atorvastatin significantly suppressed preadipocyte differentiation, whereas when each compound was used alone, there was no inhibitory effect. Additionally, cotreatment with genistein and atorvastatin significantly downregulated adipogenic marker proteins, including mitogen-activated protein kinases (MAPKs), peroxisome proliferator-activated receptor γ (PPARγ), CCAAT/enhancer-binding protein alpha (C/EBPα), glucocorticoid receptor (GR), and CCAAT/enhancer-binding protein β (C/EBPβ). This is the first evidence of the combined antiadipogenic effects of genistein and atorvastatin. Although additional experiments are required, combinational treatment with genistein and atorvastatin may be an alternative treatment for menopause-associated lipid metabolic disorders and obesity.https://www.mdpi.com/2218-273X/11/7/1052genisteinatorvastatinadipocytesadipogenesis
spellingShingle Dahae Lee
Ji-Youn Kim
Hae-Won Kim
Jeong-Eun Yoo
Ki Sung Kang
Combined Beneficial Effect of Genistein and Atorvastatin on Adipogenesis in 3T3-L1 Adipocytes
Biomolecules
genistein
atorvastatin
adipocytes
adipogenesis
title Combined Beneficial Effect of Genistein and Atorvastatin on Adipogenesis in 3T3-L1 Adipocytes
title_full Combined Beneficial Effect of Genistein and Atorvastatin on Adipogenesis in 3T3-L1 Adipocytes
title_fullStr Combined Beneficial Effect of Genistein and Atorvastatin on Adipogenesis in 3T3-L1 Adipocytes
title_full_unstemmed Combined Beneficial Effect of Genistein and Atorvastatin on Adipogenesis in 3T3-L1 Adipocytes
title_short Combined Beneficial Effect of Genistein and Atorvastatin on Adipogenesis in 3T3-L1 Adipocytes
title_sort combined beneficial effect of genistein and atorvastatin on adipogenesis in 3t3 l1 adipocytes
topic genistein
atorvastatin
adipocytes
adipogenesis
url https://www.mdpi.com/2218-273X/11/7/1052
work_keys_str_mv AT dahaelee combinedbeneficialeffectofgenisteinandatorvastatinonadipogenesisin3t3l1adipocytes
AT jiyounkim combinedbeneficialeffectofgenisteinandatorvastatinonadipogenesisin3t3l1adipocytes
AT haewonkim combinedbeneficialeffectofgenisteinandatorvastatinonadipogenesisin3t3l1adipocytes
AT jeongeunyoo combinedbeneficialeffectofgenisteinandatorvastatinonadipogenesisin3t3l1adipocytes
AT kisungkang combinedbeneficialeffectofgenisteinandatorvastatinonadipogenesisin3t3l1adipocytes